| Aktie | Ticker | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | Investment ($) | QoQ ($) | QoQ (%) | ||
| 2.148.421.589 $ | -464.238.862 $ | -23,8 % | 2.872.723.178 $ | -120.268.791 $ | -10,5 % | 3.330.865.767 $ | -298.658.637 $ | +6,5 % | 3.629.524.404 $ | +694.581.832 $ | +45,8 % | ||
| BANK OF AMERICA CORP /DE/ | BAC | 700.855.376 $ | -104.315.859 $ | -13,0 % | 805.171.235 $ | +165.039.946 $ | +25,8 % | 640.131.289 $ | -229.125.124 $ | -26,4 % | 869.256.413 $ | +694.974.194 $ | +398,8 % |
| dLocal Ltd | DLO | 605.137.334 $ | -54.588.333 $ | -8,3 % | 659.725.667 $ | -6.531.938 $ | -1,0 % | 666.257.605 $ | -58.444.316 $ | -8,1 % | 724.701.921 $ | +191.720.085 $ | +36,0 % |
| Alignment Healthcare, Inc. | ALHC | 260.062.727 $ | -163.749.384 $ | -38,6 % | 423.812.111 $ | -192.094.411 $ | -31,2 % | 615.906.522 $ | -519.789.152 $ | -45,8 % | |||
| XP Inc. | XP | 391.579.172 $ | +19.994.365 $ | +5,4 % | 371.584.807 $ | -107.893.396 $ | -22,5 % | 479.478.203 $ | -35.980.004 $ | -7,0 % | 515.458.207 $ | +108.214.378 $ | +26,6 % |
| Akero Therapeutics, Inc. | 272.249.798 $ | -33.715.855 $ | -11,0 % | 305.965.653 $ | +94.093.778 $ | +44,4 % | |||||||
| ALKAMI TECHNOLOGY, INC. | ALKT | 240.338.547 $ | -36.304.897 $ | -13,1 % | 276.643.444 $ | -21.224.919 $ | -7,1 % | 297.868.363 $ | +7.158.478 $ | +2,5 % | 290.709.885 $ | +37.520.287 $ | +14,8 % |
| Centessa Pharmaceuticals plc | CNTA | 53.813.848 $ | -99.190.204 $ | -64,8 % | 153.004.052 $ | -81.780.035 $ | -34,8 % | 234.784.087 $ | +107.564.998 $ | +84,6 % | 127.219.089 $ | -12.005.454 $ | -8,6 % |
| Revolution Medicines, Inc. | RVMD | 68.832.675 $ | -155.217.040 $ | -69,3 % | 224.049.715 $ | +108.493.927 $ | +93,9 % | 115.555.788 $ | +115.555.788 $ | ||||
| Webull Corp | BULL | 243.917 $ | -150.923 $ | -38,2 % | 394.840 $ | -106.076.403 $ | -99,6 % | 106.471.243 $ | +20.980.553 $ | +24,5 % | 85.490.690 $ | +85.490.690 $ | |
| Nurix Therapeutics, Inc. | NRIX | 63.578.908 $ | -29.320.198 $ | -31,6 % | 92.899.106 $ | +92.899.106 $ | |||||||
| Royalty Pharma plc | RPRX | 52.920.000 $ | -1.125.000 $ | -2,1 % | 54.045.000 $ | +7.350.000 $ | +15,7 % | ||||||
| RISKIFIED LTD. | RSKD | 20.873.992 $ | -5.591.248 $ | -21,1 % | 26.465.240 $ | +1.544.249 $ | +6,2 % | 24.920.991 $ | -1.650.749 $ | -6,2 % | 26.571.740 $ | +1.970.249 $ | +8,0 % |
| Adagene Inc. | ADAG | 7.526.855 $ | +66.249 $ | +0,9 % | 7.460.606 $ | +1.645.159 $ | +28,3 % | ||||||
| ALUMIS INC. | ALMS | 5.177.145 $ | +1.284.555 $ | +33,0 % | 3.892.590 $ | +3.892.590 $ | |||||||
| Grove Collaborative Holdings, Inc. | GROV | 3.167.820 $ | +445.475 $ | +16,4 % | 2.722.345 $ | -989.944 $ | -26,7 % | 3.712.289 $ | +866.201 $ | +30,4 % | 2.846.088 $ | -494.972 $ | -14,8 % |
| 2.148.421.589 $ | -464.238.862 $ | -23,8 % | 2.872.723.178 $ | -120.268.791 $ | -10,5 % | 3.330.865.767 $ | -298.658.637 $ | +6,5 % | 3.629.524.404 $ | +694.581.832 $ | +45,8 % | ||